104065-95-4 Usage
Uses
Used in Dye and Pigment Industry:
2-Isobutoxyaniline is used as a chemical intermediate for the production of dyes and pigments, contributing to the coloration and stability of these products.
Used in Pharmaceutical Industry:
2-Isobutoxyaniline is used as a chemical intermediate in the synthesis of pharmaceuticals, aiding in the development of new drugs and medications.
Used in Agrochemical Industry:
2-Isobutoxyaniline is used as a chemical intermediate in the synthesis of agrochemicals, supporting the creation of products for agricultural applications.
Used in Industrial Product Manufacturing:
2-Isobutoxyaniline is used as a chemical intermediate in the manufacturing of various industrial products, playing a role in the production process and enhancing the final product's properties.
Check Digit Verification of cas no
The CAS Registry Mumber 104065-95-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,4,0,6 and 5 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 104065-95:
(8*1)+(7*0)+(6*4)+(5*0)+(4*6)+(3*5)+(2*9)+(1*5)=94
94 % 10 = 4
So 104065-95-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO/c1-8(2)7-12-10-6-4-3-5-9(10)11/h3-6,8H,7,11H2,1-2H3
104065-95-4Relevant academic research and scientific papers
A structure—activity relationship study of bis-benzamides as inhibitors of androgen receptor—coactivator interaction
Lee, Tae-Kyung,Ravindranathan, Preethi,Sonavane, Rajni,Raj, Ganesh V.,Ahn, Jung-Mo
supporting information, (2019/08/07)
The interaction between androgen receptor (AR) and coactivator proteins plays a critical role in AR-mediated prostate cancer (PCa) cell growth, thus its inhibition is emerging as a promising strategy for PCa treatment. To develop potent inhibitors of the
NOVEL USE OF THIENOPYRIMIDINES
-
Page/Page column 39, (2010/11/27)
The present invention relates to the use of thienopyrimidine compounds for the production of pharmaceutical compositions for the treatment of inflammatory diseases.
THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS
-
Page/Page column 56, (2010/11/25)
The present invention relates to novel pharmaceutical compositions of general formula (I) comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
